Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.
Acurx Pharmaceuticals has raised $7.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Acurx Pharmaceuticals's investors include Health Holland.
Acurx Pharmaceuticals is headquartered in White Plains, United States.
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.
Acurx Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Acurx Pharmaceuticals — Funding & Investors." VCBacked, April 16, 2026, https://www.vcbacked.co/company/acurx-pharmaceuticals. Accessed August 16, 2026.
VCBacked. (2026). Acurx Pharmaceuticals — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/acurx-pharmaceuticals
{{cite web |title=Acurx Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/acurx-pharmaceuticals |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated